Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endothelial SGLT1 and 2 - CNRS - Centre national de la recherche scientifique Access content directly
Journal Articles Vascular Pharmacology Year : 2022

Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endothelial SGLT1 and 2

Fichier principal
Vignette du fichier
BruckertC_VascPharmacol2022.pdf (8.46 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03795631 , version 1 (04-10-2022)

Identifiers

Cite

Christophe Bruckert, Kensuke Matsushita, Ali Mroueh, Said Amissi, Cyril Auger, et al.. Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endothelial SGLT1 and 2. Vascular Pharmacology, 2022, 146, pp.107095. ⟨10.1016/j.vph.2022.107095⟩. ⟨hal-03795631⟩
18 View
19 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More